BMS-963272
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-963272, covering 2015-07-22 to 2015-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects [Phase 1]